Skip Navigation

AIDSInfo logo
Vaccines Search
Preventive HIV Vaccine       Trials (For HIV-negative      individuals)
New and Recruiting Trials
Closed Trials
Therapeutic AIDS Vaccine      Trials (For HIV-positive      individuals)
New and Recruiting Trials
Closed Trials
 Home > Vaccines > Search Vaccines
20 studies were found.

TerminatedEffects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV
Condition: HIV Infections
En español
CompletedVaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Condition: HIV Infections
En español
CompletedEffectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination
Condition: HIV Infections
En español
TerminatedEffectiveness of Adding Remune to Your Current Anti-HIV Drug Combination
Condition: HIV Infections
En español
CompletedA Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
Condition: HIV Infections
En español
CompletedA Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
Condition: HIV Infections
En español
CompletedTherapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
Condition: HIV Infections
CompletedActive Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Condition: HIV Infections; Pregnancy
CompletedA Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
Condition: HIV Infections
TerminatedSafety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
Condition: HIV Infections; HIV Seronegativity
CompletedA Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
Condition: HIV Infections
CompletedPhase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
Condition: HIV Infections
CompletedA Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection
Condition: HIV Infections
CompletedA Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Condition: HIV Infections
CompletedA Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells
Condition: HIV Infections
CompletedImmune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
Condition: HIV Infections
CompletedA Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3
Condition: HIV Infections
TerminatedActive Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Condition: HIV Infections; Pregnancy; HIV Seronegativity
CompletedHIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs
Condition: HIV Infections
CompletedA Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)
Condition: HIV Infections